-
dsm-firmenich secures UK and EU approvals for HMO ingredients
The UK approval, effective June 28, marks the first two HMO approvals assessed by the Food Standards Agency (FSA) and Food Standards Scotland (FSS) in post-Brexit UK. Not long after, the European Commission authorized the LNFP-I/2′-FL mixture. The supplier noted that it is the first to receive approval for LNFP-I. The approvals enable dsm-firmenich to…
-
Evonikโs synbiotic enhances omega-3 health benefits: Study
The researchers from Germany compared the efficacy of a synbiotic comprisingย DSM-Firmenichโs bacterial strainย Bacillus megateriumย โDSM 32963 and omega-3 polyunsaturated fatty acid (nโ-3 PUFA) fromย AvailOmโ, against a placebo, or fish oil with a similarย nโ-3 PUFA content, in 72 healthy participants over 28 days.ย Results published in the journalย Nutrientsโย showed the synbiotic increased circulating specialized pro-resolving mediators (SPM) precursor…
-
Lallemand and dsm-firmenich partner for synbiotic infant nutrition solutions
The offering aims to support the establishment of a microbiome closer to that of breastfed infants, the development of the immune system, the gut microbiome and optimal developmental trajectoriesโnarrowing the gap in outcomes between breastfed and non-breastfed infants. “Our partnership with Lallemand Health Solutions represents a significant milestone in the early-life nutrition market,” said James…
-
dsm-firmenich to separate animal nutrition arm in light of โunprecedentedโ vitamin prices
In a statement released today (Feb 15thโ) the firm said that removal of the Animal Nutrition & Health (ANH) segment should strongly reduce exposure to vitamins earnings volatility and reduce capital intensity after witnessing unprecedented cyclical pressure on vitamin prices in the animal marketsโ. The news comes on the same day (Feb 15th) that the…